Protagonist Therapeutics, Inc. (PTGX)
102.37
+0.19
(+0.19%)
USD |
NASDAQ |
May 18, 13:20
Protagonist Therapeutics Research and Development Expense (Quarterly) : 46.74M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Johnson & Johnson | 3.495B |
| AbbVie, Inc. | 2.472B |
| Insmed, Inc. | 209.48M |
| Madrigal Pharmaceuticals, Inc. | 108.31M |
| PTC Therapeutics, Inc. | 100.87M |